Thailand Convention and Exhibition Bureau (Public Organization) or TCEB continues to promote MICE City as a mechanism that supports the Thai government's income distribution policy. Working under...

(Gartner Identity & Access Management Summit – Booth #224) -- SSH.COM and Ubisecure today announced a partnership designed to help organizations connect strong identity with Privileged Access...

Sany Construction Industry ("the Company"), Sany Group's residential construction subsidiary and a world leader in the manufacture of engineering machinery and equipment, concluded its...

A total of 118 cooperative projects worth more than 209 billion yuan (about 30 billion U.S. dollars) have been signed at the Fifth World Green Development Investment and Trade Expo which kicked off in

LABWorld China 2019, hosted by CCCMHPI, UBM EMEA and UBM Sinoexpo, will be held at Shanghai New International Expo Centre (SNIEC) on June 18-20, 2019. As an industry weather vane, LABWorld China...

Last month, Synergy Consultants & CPAs hosted their 3rd annual Dental Business & Legal Symposium in Oxon Hill, Maryland. The nationwide two-day event captured the attention of more than 280 dental...

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced the results of up to seven years of clinical trial follow-up for IMBRUVICA® (ibrutinib) monotherapy in...

MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that results from an ongoing Phase 1b study support the...

Aprea Therapeutics presented results at the 2018 ASH Annual Meeting from its Phase Ib/II clinical study in MDS. The ongoing study is evaluating the safety and efficacy of APR-246 in combination...

Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today highlighted updated results from its ongoing Phase...

Today during the 60th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, presenters of three studies will highlight how recent technological developments are...

Novartis announced results of a retrospective, real-world evidence study in patients with immune thrombocytopenia (ITP) treated with Promacta® (eltrombopag), compared to other second-line...

Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer, today announced that the...

Petra Pharma Corporation, a drug development company focused on novel therapies that modulate phosphoinositide (PI) signaling pathways, today presented preclinical data in an oral presentation at...

Novartis today announced longer-term analyses of both ELIANA and JULIET, the pivotal clinical trials of Kymriah (tisagenlecleucel) in children and young adult patients with relapsed or refractory...

RogCon Biosciences (RogCon), a biotechnology company focused on discovering and developing novel therapeutics for children suffering from SCN2A mutations, today announced preclinical data in a...

100% overall and 80% complete response rate in 10 patients with relapsed or refractory follicular lymphoma treated with 5 mg or more of REGN1979 Plan to initiate in 2019 a potentially...

MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced preclinical data presented at the 2018 American Society of...

Tolero Pharmaceuticals, Inc., a clinical-stage company focused on developing novel therapeutics for hematological and oncological diseases, today presented new data from the ongoing Phase 2 Zella...

New data from a post hoc analysis of the Phase II SUSTAIN study of crizanlizumab -- a once-a-month, humanized anti-P-selectin monoclonal antibody infusion being investigated for the treatment of...

Today, the Multiple Myeloma Research Foundation (MMRF) announced new discoveries driven by its landmark CoMMpass StudySM into defining myeloma subtypes, identifying novel therapeutic targets for...

Dairy innovators JoeFroyo are proud to announce their lactose-free, probiotic Functional Cold Brew™ product is a semi-finalist in the New Beverage Showdown at BevNET Live Winter 2018, taking...

Community Brands, the leading provider of cloud-based software for associations, nonprofits, schools and faith-based organizations, today released an all-new feature set that includes the ability...

CME Group announced today that John Pietrowicz, Chief Financial Officer, and Sean Tully, Senior Managing Director and Global Head of Financial and OTC Products, will present at the Goldman Sachs...

Dana Incorporated (NYSE: DAN) announced today it will participate in the Bank of America Merrill Lynch Leveraged Finance Conference on Dec. 4, 2018. Senior Vice President and Treasurer Timothy...